These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2126731)
1. Acute lead arsenate poisoning. Geddes R Aust N Z J Med; 1990 Oct; 20(5):750-1. PubMed ID: 2126731 [No Abstract] [Full Text] [Related]
2. Results with newer therapeutic methods in large animal practice. II. The role of fluid and electrolyte therapy in lead arsenate poisoning. HAMMOND PB; HOYT HH; NELSON BJ J Am Vet Med Assoc; 1957 Jul; 131(2):91-2. PubMed ID: 13438775 [No Abstract] [Full Text] [Related]
3. Acute lead arsenate poisoning. Tallis GA Aust N Z J Med; 1989 Dec; 19(6):730-2. PubMed ID: 2517192 [TBL] [Abstract][Full Text] [Related]
4. The use of chelating agents in occupational lead poisoning. Porru S; Alessio L Occup Med (Lond); 1996 Feb; 46(1):41-8. PubMed ID: 8672793 [TBL] [Abstract][Full Text] [Related]
5. [Current diagnosis and treatment of lead poisoning]. Klein M; Kaminsky P; Duc ML; Duc M Rev Med Interne; 1994 Feb; 15(2):101-9. PubMed ID: 8059115 [TBL] [Abstract][Full Text] [Related]
6. [Poisoning caused by lead arsenate; group poisoning, with special reference to hemolytic anemia caused by lead arsenate]. PUCCINI C Minerva Medicoleg; 1955; 75(3):77-84. PubMed ID: 13244506 [No Abstract] [Full Text] [Related]
7. Use of chelating agents in treatment of metal poisoning (with special emphasis on lead). FOREMAN H Fed Proc; 1961 Sep; 20(3)Pt 2():191-6. PubMed ID: 13894041 [No Abstract] [Full Text] [Related]
8. Lead poisoning: successes and 21st century challenges. Laraque D; Trasande L Pediatr Rev; 2005 Dec; 26(12):435-43. PubMed ID: 16327024 [No Abstract] [Full Text] [Related]
9. What is the appropriate treatment regimen for a lead-exposed employee with a blood lead level of 60 micrograms/dl? J Occup Med; 1993 Sep; 35(9):885. PubMed ID: 8229336 [No Abstract] [Full Text] [Related]
10. [Recent onset cases of lead poisoning among painters]. Nakamura K; Kitahara T; Taoda K Sangyo Eiseigaku Zasshi; 2015; 57(5):241-3. PubMed ID: 26105568 [No Abstract] [Full Text] [Related]
11. [Case reports and experimental findings on lead arsenate poisoning]. ANTONIOTTI F; MURINO P Acta Med Leg Soc (Liege); 1957; 10(3):249-63. PubMed ID: 13508131 [No Abstract] [Full Text] [Related]
12. Lead and arsenic poisoning with special reference to the toxicity of lead arsenate spray residues. WILLIAMS HA R Soc Health J; 1958; 78(6):732-40. PubMed ID: 13615206 [No Abstract] [Full Text] [Related]
13. [Chelating agents in lead poisoning]. ROCHE L; BADINAND A; LEJEUNE E Arch Mal Prof; 1960; 21():1-12. PubMed ID: 14438083 [No Abstract] [Full Text] [Related]
14. [The use of chelating agents in the treatment of lead poisoning]. de TAVARES JF; PORTO AL J Med (Oporto); 1961 Apr; 44():925-9. PubMed ID: 13775519 [No Abstract] [Full Text] [Related]
15. [Study of 34 cases of lead arsenate poisoning in two insecticide factories]. CAPELLINI A; PARMEGGIANI L; SARTORELLI E; MARTELLI GC Med Lav; 1955 Mar; 46(3):147-57. PubMed ID: 14393296 [No Abstract] [Full Text] [Related]
16. [Transitory monolateral miosis caused by lead arsenate poisoning]. KAHNEMANN F Ann Ottalmol Clin Ocul; 1957 Nov; 83(11):653-62. PubMed ID: 13509498 [No Abstract] [Full Text] [Related]
17. [Diagnosis in occupational poisoning by lead arsenate]. CORSI GC Riv Infort Mal Prof; 1960; 47():169-77. PubMed ID: 13695682 [No Abstract] [Full Text] [Related]
18. Penicillamine as lead-chelating substance in man. OHLSSON WT Br Med J; 1962 May; 1(5290):1454-6. PubMed ID: 14481385 [No Abstract] [Full Text] [Related]
19. Potential of the liposomal approach to metal chelation therapy. Rahman YE Front Biol; 1979; 48():625-52. PubMed ID: 227757 [No Abstract] [Full Text] [Related]
20. [Lead arsenate as an underestimated cause of polyneuropathy in rural environment: description of two cases]. FoĆ V; Gilioli R; Rizzi B; Merluzzi F Riv Patol Nerv Ment; 1976; 96(6):363-77. PubMed ID: 1023347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]